Challenges and hopes for Alzheimer's disease

SA Tatulian - Drug discovery today, 2022 - Elsevier
Recent drug development efforts targeting Alzheimer's disease (AD) have failed to produce
effective disease-modifying agents for many reasons, including the substantial …

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

C Gao, J Jiang, Y Tan, S Chen - Signal transduction and targeted …, 2023 - nature.com
Microglia activation is observed in various neurodegenerative diseases. Recent advances in
single-cell technologies have revealed that these reactive microglia were with high spatial …

Amelioration of Alzheimer's disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow

C Xie, XX Zhuang, Z Niu, R Ai, S Lautrup… - Nature Biomedical …, 2022 - nature.com
A reduced removal of dysfunctional mitochondria is common to aging and age-related
neurodegenerative pathologies such as Alzheimer's disease (AD). Strategies for treating …

Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level

ECB Johnson, EK Carter, EB Dammer, DM Duong… - Nature …, 2022 - nature.com
The biological processes that are disrupted in the Alzheimer's disease (AD) brain remain
incompletely understood. In this study, we analyzed the proteomes of more than 1,000 brain …

Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial

G Koch, EP Casula, S Bonnì, I Borghi, M Assogna… - Brain, 2022 - academic.oup.com
Repetitive transcranial magnetic stimulation (rTMS) is emerging as a non-invasive
therapeutic strategy in the battle against Alzheimer's disease. Alzheimer's disease patients …

The glymphatic system: a novel component of fundamental neurobiology

LM Hablitz, M Nedergaard - Journal of Neuroscience, 2021 - Soc Neuroscience
Throughout the body, lymphatic fluid movement supports critical functions including
clearance of excess fluid and metabolic waste. The glymphatic system is the analog of the …

Multifunctional materials for implantable and wearable photonic healthcare devices

GH Lee, H Moon, H Kim, GH Lee, W Kwon… - Nature Reviews …, 2020 - nature.com
Numerous light-based diagnostic and therapeutic devices are routinely used in the clinic.
These devices have a familiar look as items plugged in the wall or placed at patients' …

[HTML][HTML] Current understanding of Alzheimer's disease diagnosis and treatment

J Weller, A Budson - F1000Research, 2018 - ncbi.nlm.nih.gov
Alzheimer's disease is the most common cause of dementia worldwide, with the prevalence
continuing to grow in part because of the aging world population. This neurodegenerative …

[HTML][HTML] Neurocognitive, physiological, and biophysical effects of transcranial alternating current stimulation

M Wischnewski, I Alekseichuk, A Opitz - Trends in Cognitive Sciences, 2023 - cell.com
Transcranial alternating current stimulation (tACS) can modulate human neural activity and
behavior. Accordingly, tACS has vast potential for cognitive research and brain disorder …

Modeling Alzheimer's disease with iPSC-derived brain cells

J Penney, WT Ralvenius, LH Tsai - Molecular psychiatry, 2020 - nature.com
Alzheimer's disease is a devastating neurodegenerative disorder with no cure. Countless
promising therapeutics have shown efficacy in rodent Alzheimer's disease models yet failed …